|
Showing the most relevant articles for your search:NASDAQ:ACLA 1 | Date | Time | Source | Headline | Symbol | Company | | 12/10/2004 | 1:31PM | PR Newswire (US) | ViroLogic and ACLARA Announce Stockholder Approval of Merger | NASDAQ:ACLA | Aclara Biosciences, (MM) |
| 12/02/2004 | 9:00AM | PR Newswire (US) | Iceland Genomics Corporation and ACLARA Collaborating on Cancer Biomarkers | NASDAQ:ACLA | Aclara Biosciences, (MM) |
| 11/09/2004 | 7:45AM | PR Newswire (US) | ACLARA Announces Third Quarter 2004 Financial Results | NASDAQ:ACLA | Aclara Biosciences, (MM) |
| 11/08/2004 | 7:00AM | PR Newswire (US) | ViroLogic and ACLARA to Mail Revised Definitive Proxy for Proposed Merger | NASDAQ:ACLA | Aclara Biosciences, (MM) |
| 11/04/2004 | 7:45AM | PR Newswire (US) | Clinical Data Presented at ESMO Shows ETAG(TM) System's Potential in Predicting Response to Cancer Treatment | NASDAQ:ACLA | Aclara Biosciences, (MM) |
| 10/27/2004 | 9:01AM | PR Newswire (US) | Manuel Hidalgo, M.D., Ph.D., Joins ACLARA BioSciences Scientific Advisory Board | NASDAQ:ACLA | Aclara Biosciences, (MM) |
| 10/19/2004 | 8:00AM | PR Newswire (US) | ViroLogic and ACLARA BioSciences Revise Merger Terms | NASDAQ:ACLA | Aclara Biosciences, (MM) |
| 10/05/2004 | 8:45AM | PR Newswire (US) | ACLARA and GlaxoSmithKline Evaluating eTag(TM) Technology for Patient Selection for Targeted Cancer Therapies | NASDAQ:ACLA | Aclara Biosciences, (MM) |
| 09/30/2004 | 8:45AM | PR Newswire (US) | ACLARA Data at EORTC-NCI-AACR Symposium Demonstrates ETAG(TM) System Potential in Cancer Drug Development and Treatment Prognosi | NASDAQ:ACLA | Aclara Biosciences, (MM) |
| 09/28/2004 | 6:04PM | PR Newswire (US) | ViroLogic and ACLARA Mail Definitive Proxy for Proposed Merger | NASDAQ:ACLA | Aclara Biosciences, (MM) |
| 08/04/2004 | 5:30PM | PR Newswire (US) | Aclara Announces Second Quarter Financial Results | NASDAQ:ACLA | Aclara Biosciences, (MM) |
| 07/07/2004 | 8:00AM | PR Newswire (US) | ACLARA BioSciences Appoints Roy S. Herbst, M.D., Ph.D., To Scientific Advisory Board | NASDAQ:ACLA | Aclara Biosciences, (MM) |
| 06/14/2004 | 8:45AM | PR Newswire (US) | ACLARA BioSciences and Tokyo Metropolitan Institute of Medical Science (Rinshoken) to Conduct Breast Cancer Biomarker Study | NASDAQ:ACLA | Aclara Biosciences, (MM) |
| 06/10/2004 | 8:11PM | PR Newswire (US) | Aclara to Present at Needham Third Annual Biotechnology Conference | NASDAQ:ACLA | Aclara Biosciences, (MM) |
| 06/10/2004 | 8:45AM | PR Newswire (US) | Prominent Oncologist Appointed to ACLARA Scientific Advisory Board | NASDAQ:ACLA | Aclara Biosciences, (MM) |
| 06/03/2004 | 9:00AM | PR Newswire (US) | ACLARA to Host Investor Briefing and Webcast at ASCO Annual Meeting Monday June 7, 2004 at 7:00 A.M. Central time | NASDAQ:ACLA | Aclara Biosciences, (MM) |
| 06/02/2004 | 5:20PM | PR Newswire (US) | ACLARA eTag Technology to be Discussed at ASCO Annual Meeting | NASDAQ:ACLA | Aclara Biosciences, (MM) |
| 06/01/2004 | 8:30AM | PR Newswire (US) | ViroLogic and ACLARA BioSciences Announce Merger | NASDAQ:ACLA | Aclara Biosciences, (MM) |
| 04/29/2004 | 9:30AM | PR Newswire (US) | ACLARA Announces First Quarter Financial Results | NASDAQ:ACLA | Aclara Biosciences, (MM) |
| 04/05/2004 | 9:30AM | PR Newswire (US) | ACLARA Receives Four U.S. Patents for Its eTag(TM) and Nanofluidic Technologies | NASDAQ:ACLA | Aclara Biosciences, (MM) |
| 12/11/2003 | 8:00AM | PR Newswire (US) | John Weinstein, M.D. Ph.D. Appointed to ACLARA Scientific Advisory Board | NASDAQ:ACLA | Aclara Biosciences, (MM) |
| 12/04/2003 | 8:30AM | PR Newswire (US) | ACLARA and Cell Signaling Technology, Inc. Enter into Antibody Supply Agreement | NASDAQ:ACLA | Aclara Biosciences, (MM) |
| 11/05/2003 | 4:00PM | PR Newswire (US) | ACLARA Announces Third Quarter 2003 Financial Results | NASDAQ:ACLA | Aclara Biosciences, (MM) |
| 10/29/2003 | 2:00PM | PR Newswire (US) | ADVISORY: ACLARA BioSciences, Inc. to Announce Q3 2003 Financial Results On November 5, 2003 | NASDAQ:ACLA | Aclara Biosciences, (MM) |
|
Showing the most relevant articles for your search:NASDAQ:ACLA 1 |
|